  Traditional Indian (Ayurvedic) and Chinese herbal medicines have been used in
the treatment of a variety of diseases for thousands of years because of their
natural origin and lesser side effects. However, the safety and efficacy data
(including dose and quality parameters) on most of these traditional medicines
are far from sufficient to meet the criteria needed to support their world-wide
therapeutic use. Also, the mechanistic understanding of most of these herbal
medicines is still lacking due to their complex components which further limits
their wider application and acceptance. Metabolomics -a novel approach to
reveal altered metabolism (biochemical effects) produced in response to a
disease or its therapeutic intervention- has huge potential to assess the
pharmacology and toxicology of traditional herbal medicines (THMs). Therefore,
it is gradually becoming a mutually complementary technique to genomics,
transcriptomics and proteomics for therapeutic evaluation of pharmaceutical
products (including THMs); the approach is so called pharmaco-metabolomics. The
whole paradigm is based on its ability to provide metabolic signatures to
confirm the diseased condition and then to use the concentration profiles of
these biomarkers to assess the therapeutic response. Nuclear magnetic resonance
(NMR) spectroscopy coupled with multivariate data analysis is currently the
method of choice for pharmaco-metabolomics studies owing to its unbiased,
non-destructive nature and minimal sample preparation requirement. In recent
past, dozens of NMR based pharmaco-metabolomic studies have been devoted to
prove the therapeutic efficacy/safety and to explore the underlying mechanisms
of THMs, with promising results. The current perspective article summarizes
various such studies in addition to describing the technical and conceptual
aspects involved in NMR based pharmaco-metabolomics.
